Hearing health

French reforms and US vaccinations benefit Demant in corona-struck times

Demant's Tuesday upgrade was highly driven by the French market but the firm has also advanced in the rest of the world, and the hearing aid firm's CEO Søren Nielsen is confident that Demant will be able to keep up the pace for the rest of the year.
Demant President & CEO Søren Nielsen | Photo: Kenneth Lysbjerg Koustrup/ERH
Demant President & CEO Søren Nielsen | Photo: Kenneth Lysbjerg Koustrup/ERH
BY ELIZABETH MØNSTED JOHANSEN, TRANSLATED BY NIELSINE NIELSEN & CATHERINE BRETT

Demant has raised its guidance for 2021 based on looking back on the first three months, rather than ahead to the next nine, says Søren Nielsen, CEO of Demant, to MedWatch.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
    • Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
    Must contain at least 2 characters
    Must contain at least 2 characters

    Get full access for you and your coworkers

    Start a free company trial today

    Share article

    Related articles

    Sign up for our newsletter

    Stay ahead of development by receiving our newsletter on the latest sector knowledge.

    Newsletter terms

    Front page now

    Further reading

    Jobs